From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance
Thomas Litman(University of Copenhagen), Susan E. Bates(New York Oncology Hematology)
Cited by 685
Related Papers
Comparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and Dasatinib
|Drug Metabolism and Disposition|2010|216
Histone deacetylase inhibitor‐mediated cell death is distinct from its global effect on chromatin
|Molecular Oncology|2014|49
R-Loop–Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin
|Molecular Cancer Research|2021|30